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the Limits of Linked suppression  
for regulatory t cells
Toshiro Ito1 , Akira Yamada1 , Ibrahim Batal2 , Melissa Y. Yeung2 , Martina M. McGrath2 , 
Mohamed H. Sayegh2 , Anil Chandraker2 and Takuya Ueno1,2*
1 Transplantation Unit, Surgical Services, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA, 
2 Transplantation Research Center, Brigham and Women’s Hospital and Children’s Hospital, Harvard Medical School, 
Boston, MA, USA
Background: We have previously found that CD4+CD25+ regulatory T cells (Tregs) can 
adoptively transfer tolerance after its induction with costimulatory blockade in a mouse 
model of murine cardiac allograft transplantation. In these experiments, we tested an 
hypothesis with three components: (1) the Tregs that transfer tolerance have the capacity 
for linked suppression, (2) the determinants that stimulate the Tregs are expressed by the 
indirect pathway, and (3) the donor peptides contributing to these indirect determinants 
are derived from donor major histocompatibility complex (MHC) antigens (Ags).
Methods: First heart transplants were performed from the indicated donor strain to B10.
D2 recipients along with costimulatory blockade treatment (250 μg i.p. injection of MR1 
on day 0 and 250 μg i.p. injection of CTLA-4 Ig on day 2). At least 8 weeks later, a second 
heart transplant was performed to a new B10.D2 recipient who had been irradiated with 
450 cGy. This recipient was given 40 × 106 naive B10.D2 spleen cells + 40 × 106 B10.D2 
spleen cells from the first (tolerant) recipient. We performed three different types of heart 
transplants using various donors.
results: (1) Tregs suppress the graft rejection in an Ag-specific manner. (2) Tregs gener-
ated in the face of MHC disparities suppress the rejection of grafts expressing third party 
MHC along with tolerant MHC.
conclusion: The limits of linkage appear to be quantitative and not universally deter-
mined by either the indirect pathway or by peptides of donor MHC Ags.
Keywords: costimulation, indirect pathway, MHc class ii, tolerance, regulatory t cells
iNtrODUctiON
The physiologically unusual stimulation of T cells by donor antigen-presenting cells (APCs) has 
been called “direct” recognition, whereas stimulation by self-APCs, presenting peptides of donor 
origin, has been called “indirect” recognition. Direct recognition has been believed to be the major 
pathway involved in allograft rejection due to three basic observations, namely, (1) direct stimulation 
is very strong in a primary allogenic mixed lymphocyte reaction, (2) depletion of donor APCs can 
Abbreviations: Ags, antigens; APCs, antigen-presenting cells; MHC, major histocompatibility complex; MST, median survival 
time; Tregs, regulatory T cells.
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sometimes prolong allograft survival, and (3) donor major histo-
compatibility complex (MHC) antigens (Ags) are more important 
than minor Ags in causing graft rejection (1). Matching for MHC 
Ags achieves better allograft survival. Lechler and Batchelor 
showed the importance of MHC class II matching compared 
to MHC class I matching at least in the long-term survival (2). 
However, there are several remarkable reports of consequences 
of T cells responding via the indirect pathway. These reports 
showed the indirect pathway (a) helps for priming alloreactive 
CD8 T cells (3, 4), (b) is essential for tolerance induction in some 
models (5, 6), and (c) is involved in chronic transplant rejection 
(7, 8). In addition, several papers have shown the importance of 
an indirect response in allograft rejection (1, 3, 9, 10). Indirect 
allorecognition contributes not only to acute graft rejection 
(2, 9) but also possibly to the continuing response to the allograft 
in the long term after transplantation (11). Previously, we tested 
the role of costimulatory blockade for prolonging allograft sur-
vival with using class II-deficient mice when only one or the other 
pathway of graft rejection was available. We found that to achieve 
long-term survival after costimulatory blockade requires that 
the recipient expresses MHC class II molecules (12). This result 
indicated that indefinite cardiac transplant survival could not 
be achieved in the absence of an intact indirect pathway. These 
results are consistent with the fact that at least a component of 
the regulatory T cell (Treg) response must involve recognition 
of peptides of donor Ags presented by recipient MHC molecules 
FiGUre 1 | (A) Allograft survival in B10.D2 recipients: (>100 days, n = 5, p = 0.0017 compared to control: 16.2 days, n = 5). (B) Adoptive transfer model:  
naive splenocytes transfer (n = 6), both naive and Tol. splenocytes transfer (100 days, n = 6, p = 0.0007). (c) Linkage model: B6 hearts (>100 days), B10.BR 
hearts (~23 days, n = 6, p = 0.0006) (B6 × B10.BR) F1 (>100 days, n = 4/5, p = 0.0044).
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(13). Authors also mentioned that linked suppression can also be 
induced through the indirect pathway. However, little work seems 
to have addressed their direct role in transplantation. Therefore, 
in the current study, we tested whether the Tregs that transfer 
tolerance have the capacity for linked suppression.
MetHODs AND resULts
First, we made B10.D2 (H-2d) mice tolerant to B6 (H-2b) with 
costimulatory blockade [250 μg intraperitoneal (i.p.) injection of 
MR1 on day 0 and 250 μg i.p. injection of CTLA-4 Ig on day 2] 
(Figure 1A). At least 8 weeks later, a second heart transplant was 
performed to a new B10.D2 recipient who had been irradiated with 
450 cGy. All recipient received intravenous (i.v.) injection of naive 
40 × 106 splenocytes + 40 × 106 splenocytes that are taken from the 
tolerant mice (toleralized splenocytes: Tol.) significantly prolonged 
graft survival compared to recipient received only naive splenocyte 
(12 ±  1  days compared to >100, p <  0.001) (Figure  1B). After 
these results, we considered linkage of Tregs. Next, we performed 
a second transplant from B6 mice to irradiated B10.D2 mice. The 
second donors express the same MHC and minor Ags as the first 
graft or B10.BR heart grafts differ from the first graft in their MHC 
Ags or (B6 × B10.BR) F1 mice, which express both H-2b and H-2k 
Ags. After transplant, the mice received i.v. injection of naive and 
toleralized splenocytes. All B6 hearts survived over 100 days. But 
B10.BR hearts expressing third party MHC were rejected by 23 days 
(Figure 1C). (B10.BR × B6) F1 hearts expressing third party MHC 
with tolerant MHC showed 80% survival of over 100 days; however, 
CAV was observed in some specimen. The institutional subcom-
mittee on research animal care at Massachusetts General Hospital 
approved all animal experiments.
DiscUssiON
Linked suppression has often been associated with Tregs, and 
its mechanisms must be important ones, as tolerance can be 
extended to whole MHC disparities when applied to cardiac 
transplantation. Tolerance was extended to third party transplant 
Ags, even to MHC-encoded Ags, provided they are expressed 
on the same graft as the tolerated Ags in some models (14–17). 
Thus, its mechanism of immunoregulation in transplantation is 
very important. In addition, understanding interactions between 
linked suppression and Tregs can potentially be great advantage 
in the setting of transplantation to propagate the development 
of specific unresponsiveness once the process has been initiated.
Our preliminary data showed that Tregs suppress the graft 
rejection in an Ag-specific manner and Tregs generated in the 
face of MHC disparities suppress the rejection of grafts expressing 
third party MHC along with tolerant MHC.
cONcLUsiON
The very limited comparison in this experiment will determine 
whether the patterns of gene expression can reliably distinguish a 
regulatory population from one that promotes rejection.
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